rejuvant life tabs

Juvenescence appoints Chief Scientific Officer

Latest articles

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...

Longevity supplements report: JUVICELL profile

Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement. Over the coming weeks, we will be bringing...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

Leucine, weight loss and NAD+ boosting

Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine. In the first part of...

Organoid to the rescue of the thyroid

Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism. The role of the thyroid gland is...

Changing demographics warrant solid longevity foundation

EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first. Back in January, the European Commission...
Rejuvant

Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer.

Juvenescence Ltd, a life sciences company focused on modifying aging and increasing human healthspan, has announced that Grazia Piizzi, PhD, has joined its Executive Management Team as Chief Scientific Officer.

Longevity.Technology: Juvenescence is continuing to build its power-base ahead of its IPO, which is slated to happen later this year, and the launch of Metabolic Switch, a “ketone ester fuel”, also scheduled for2021. In addition, Juvenescence acquired Portage Pharmaceuticals Ltd, and its senolytic, p53, which it is keen to test. Dr Piizzi’s extensive experience means she will be well placed to guide this process.

Juvenescence creates evidence-based and science-backed therapies based on understanding of the underlying biological causes of aging. It is focused on increasing how long people live in health by preventing the diseases of aging in the first place. The Juvenescence team includes highly experienced drug developers, entrepreneurs, marketers and investors with a significant history of success in the pharmaceutical and consumer health sectors.

Dr Piizzi has more than 15 years of experience in the global pharmaceutical and biotech industry. Most recently, she was the SVP of Small Molecules R&D and Head of Inflammation at a Flagship Pioneering start-up, Cygnal Therapeutics, decoding the links between peripheral neurons and diseases (2019-2021).

 


 

“Science is changing how we look at aging and age-related diseases. I will work with a talented team to bring that science to real products and therapies that can transform lives…”

 


 

Previously, she held the position of Executive Director, Head of Molecular Invention, at Merck Cambridge (2017-2019) to build the new Exploratory Science Center (ESC) and establish a multidisciplinary team and platform to identify opportunities in infectious diseases, microbiome, and immune-cancer-microbiome interactions. Dr Piizzi also spent 10 years at Novartis Cambridge and Basel leading global teams responsible from target ID to clinical candidate selection across multiple disease areas.

Elevant

Greg Bailey
Dr Greg Bailey, CEO, Juvenescence

Dr Greg Bailey, CEO of Juvenescence, said: “Aging is an incredibly complex biological event where multiple pathologies compromise our ability to live healthy. For any company to address and modify how we age so that we can live healthier and longer, you need to be very inventive and innovative using combinations of therapies. Dr Piizzi is an extraordinary fit because of her imagination and curiosity backed by rigorous scientific discipline. Juvenescence is very lucky to have someone with these qualities join us as our CSO. There are a number of areas that are going to be a focus for us going forward, and Dr Piizzi’s background will accelerate and optimize these opportunities [1].”

Dr Piizzi said: “I’m focused on building the portfolio, bringing new skills, assets and technologies into this company. Science is changing how we look at aging and age-related diseases. I will work with a talented team to bring that science to real products and therapies that can transform lives [1].”

Elevant

[1] https://www.juvlabs.com/news-pr/news-release/juvenescence-appoints-piizzi

Image credits: Chokniti KhongchumPexels and Juvenescence

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

New research institute focuses on science of aging

New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community. UC...

Call for £3b intervention to save lives and back health

"Levelling Up Health" Ten Year Plan would save 40,000 lives from next pandemic says cross party group, as it calls for £3 billion intervention...

Jobs in longevity? Your new career starts here

Announcing our new 'jobs in longevity' system and international 'executive search' service. As many of us enter a long-weekend there'll be some downtime to consider...

The aging society: new challenges, new economy

From increased risk aversion to changed consumption patterns, CaixaBank Research economist highlights key issues presented by aging. The world is aging, and aging fast. The...

NIA announces funding for longevity clinical trials

New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease. The NIA, which is part of the...
Supps report ad middle